You are viewing an incomplete version of our website. Please click to reload the website as full version.

Acyl-CoA Synthetase Medium-Chain Family Member 1 (ACSM1) (N-Term) Peptide

Details for Product No. ABIN698884, Supplier: Log in to see
Protein Name
  • BUCS1
  • MACS1
  • Acas3
  • Bucs1
  • Macs
Protein Region
Peptide Type
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Specificity The synthetic peptide sequence used to generate the antibody AP9284a was selected from the N-term region of human ACSM1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Background ACSM1 has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). This protein acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy-and 2,3-or 3,4-unsaturated acids (in vitro). This protein functions as GTP-dependent lipoate-activating enzyme that generates the substrate for lipoyltransferase
Restrictions For Research Use only
Storage 4
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Background publications Celis, Gromov, Cabezón et al.: "15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 7, Issue 10, pp. 1795-809, 2008 (PubMed).

Sullivan, Lin, Tzeng et al.: "Genomewide association for schizophrenia in the CATIE study: results of stage 1." in: Molecular psychiatry, Vol. 13, Issue 6, pp. 570-84, 2008 (PubMed).